Effective reimbursement models are the key to the future success of gene therapies, a new PwC report shows.
Why changes in the U.S. healthcare policy have caused healthcare costs to rise.
While aggressive early intervention may be useful for diabetes patients, that intervention must be sustained.
Cancer is the second most costly medical condition in the United States behind heart disease, and a study presented at the American Society of Clinical Oncology (ASCO) sought to better understand Medicare costs.
Physician leader Atul Gawande believes that as treatment options proliferate for cancer care and other serious illnesses, it will create a new challenge: patient communication about quality of life.
A study presented today at the American Society of Clinical Oncology (ASCO) shows that the type of health insurance and other socio-economic factors influence treatment outcomes for multiple myeloma.